世界のがん治療におけるゲノミクス市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)

GlobalInfoResearchが発行した調査報告書(GIR20SP05111)
◆英語タイトル:Global Genomics In Cancer Care Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20SP05111
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年9月23日(※2024年版があります。お問い合わせください。)
◆ページ数:123
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートでは、がん治療におけるゲノミクスの世界市場を広く調査・分析し、今後の市場展望をまとめております。がん治療におけるゲノミクスの種類別市場規模(器具、消耗品、サービス)、用途別市場規模(診断、個別化医療、創薬、開発、研究)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Illumina、Danaher、Roche、Thermo Fisher scientific、Bio-Rad、Agilent、Pacific Biosciences、Beckman Coulter、Cancer Genetics、Sigma Aldrich、Qiagen、Quest Diagnostics、GE Healthcare、PerkinElmer、Luminex、Thermo Fisher scientific、Oxford Gene Technology
・地域別グローバル市場分析 2015年-2020年
・がん治療におけるゲノミクスの北米市場(アメリカ、カナダ、メキシコ)
・がん治療におけるゲノミクスのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・がん治療におけるゲノミクスのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・がん治療におけるゲノミクスの南米市場(ブラジル、アルゼンチン)
・がん治療におけるゲノミクスの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:器具、消耗品、サービス
・用途別分析:診断、個別化医療、創薬、開発、研究
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The global Genomics In Cancer Care market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 9.4% in the forecast period of 2020 to 2025 and will expected to reach USD 22870 million by 2025, from USD 15970 million in 2019.

The Genomics In Cancer Care market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Genomics In Cancer Care market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Genomics In Cancer Care market has been segmented into:
Instruments
Consumables
Services

By Application, Genomics In Cancer Care has been segmented into:
Diagnostics
Personalized Medicine
Drug Discovery
Development
Research

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Genomics In Cancer Care market presented in the report. This section sheds light on the sales growth of different regional and country-level Genomics In Cancer Care markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Genomics In Cancer Care market.

The report offers in-depth assessment of the growth and other aspects of the Genomics In Cancer Care market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Genomics In Cancer Care Market Share Analysis
Genomics In Cancer Care competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Genomics In Cancer Care sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Genomics In Cancer Care sales, revenue and market share for each player covered in this report.

The major players covered in Genomics In Cancer Care are:
Illumina
Danaher
Roche
Thermo Fisher scientific
Bio-Rad
Agilent
Pacific Biosciences
Beckman Coulter
Cancer Genetics
Sigma Aldrich
Qiagen
Quest Diagnostics
GE Healthcare
PerkinElmer
Luminex
Thermo Fisher scientific
Oxford Gene Technology

【レポートの目次】

Table of Contents

1 Genomics In Cancer Care Market Overview
1.1 Product Overview and Scope of Genomics In Cancer Care
1.2 Classification of Genomics In Cancer Care by Type
1.2.1 Global Genomics In Cancer Care Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Genomics In Cancer Care Revenue Market Share by Type in 2019
1.2.3 Instruments
1.2.4 Consumables
1.2.5 Services
1.3 Global Genomics In Cancer Care Market by Application
1.3.1 Overview: Global Genomics In Cancer Care Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Global Genomics In Cancer Care Market by Regions
1.4.1 Global Genomics In Cancer Care Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Genomics In Cancer Care (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Genomics In Cancer Care Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Genomics In Cancer Care Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Genomics In Cancer Care Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Genomics In Cancer Care Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Genomics In Cancer Care Status and Prospect (2015-2025)
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Illumina SWOT Analysis
2.1.4 Illumina Product and Services
2.1.5 Illumina Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.2 Danaher
2.2.1 Danaher Details
2.2.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Danaher SWOT Analysis
2.2.4 Danaher Product and Services
2.2.5 Danaher Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche SWOT Analysis
2.3.4 Roche Product and Services
2.3.5 Roche Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.4 Thermo Fisher scientific
2.4.1 Thermo Fisher scientific Details
2.4.2 Thermo Fisher scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Thermo Fisher scientific SWOT Analysis
2.4.4 Thermo Fisher scientific Product and Services
2.4.5 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bio-Rad
2.5.1 Bio-Rad Details
2.5.2 Bio-Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bio-Rad SWOT Analysis
2.5.4 Bio-Rad Product and Services
2.5.5 Bio-Rad Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.6 Agilent
2.6.1 Agilent Details
2.6.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Agilent SWOT Analysis
2.6.4 Agilent Product and Services
2.6.5 Agilent Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pacific Biosciences
2.7.1 Pacific Biosciences Details
2.7.2 Pacific Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pacific Biosciences SWOT Analysis
2.7.4 Pacific Biosciences Product and Services
2.7.5 Pacific Biosciences Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.8 Beckman Coulter
2.8.1 Beckman Coulter Details
2.8.2 Beckman Coulter Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Beckman Coulter SWOT Analysis
2.8.4 Beckman Coulter Product and Services
2.8.5 Beckman Coulter Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cancer Genetics
2.9.1 Cancer Genetics Details
2.9.2 Cancer Genetics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Cancer Genetics SWOT Analysis
2.9.4 Cancer Genetics Product and Services
2.9.5 Cancer Genetics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sigma Aldrich
2.10.1 Sigma Aldrich Details
2.10.2 Sigma Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sigma Aldrich SWOT Analysis
2.10.4 Sigma Aldrich Product and Services
2.10.5 Sigma Aldrich Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.11 Qiagen
2.11.1 Qiagen Details
2.11.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Qiagen SWOT Analysis
2.11.4 Qiagen Product and Services
2.11.5 Qiagen Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.12 Quest Diagnostics
2.12.1 Quest Diagnostics Details
2.12.2 Quest Diagnostics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Quest Diagnostics SWOT Analysis
2.12.4 Quest Diagnostics Product and Services
2.12.5 Quest Diagnostics Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.13 GE Healthcare
2.13.1 GE Healthcare Details
2.13.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 GE Healthcare SWOT Analysis
2.13.4 GE Healthcare Product and Services
2.13.5 GE Healthcare Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.14 PerkinElmer
2.14.1 PerkinElmer Details
2.14.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 PerkinElmer SWOT Analysis
2.14.4 PerkinElmer Product and Services
2.14.5 PerkinElmer Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.15 Luminex
2.15.1 Luminex Details
2.15.2 Luminex Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Luminex SWOT Analysis
2.15.4 Luminex Product and Services
2.15.5 Luminex Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.16 Thermo Fisher scientific
2.16.1 Thermo Fisher scientific Details
2.16.2 Thermo Fisher scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Thermo Fisher scientific SWOT Analysis
2.16.4 Thermo Fisher scientific Product and Services
2.16.5 Thermo Fisher scientific Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
2.17 Oxford Gene Technology
2.17.1 Oxford Gene Technology Details
2.17.2 Oxford Gene Technology Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Oxford Gene Technology SWOT Analysis
2.17.4 Oxford Gene Technology Product and Services
2.17.5 Oxford Gene Technology Genomics In Cancer Care Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Genomics In Cancer Care Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Genomics In Cancer Care Players Market Share
3.2.2 Top 10 Genomics In Cancer Care Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Genomics In Cancer Care Revenue and Market Share by Regions
4.2 North America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
4.3 Europe Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
4.5 South America Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
5 North America Genomics In Cancer Care Revenue by Countries
5.1 North America Genomics In Cancer Care Revenue by Countries (2015-2020)
5.2 USA Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
5.3 Canada Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
5.4 Mexico Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6 Europe Genomics In Cancer Care Revenue by Countries
6.1 Europe Genomics In Cancer Care Revenue by Countries (2015-2020)
6.2 Germany Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6.3 UK Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6.4 France Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6.5 Russia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
6.6 Italy Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Genomics In Cancer Care Revenue by Countries
7.1 Asia-Pacific Genomics In Cancer Care Revenue by Countries (2015-2020)
7.2 China Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7.3 Japan Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7.4 Korea Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7.5 India Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
8 South America Genomics In Cancer Care Revenue by Countries
8.1 South America Genomics In Cancer Care Revenue by Countries (2015-2020)
8.2 Brazil Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
8.3 Argentina Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Genomics In Cancer Care by Countries
9.1 Middle East & Africa Genomics In Cancer Care Revenue by Countries (2015-2020)
9.2 Saudi Arabia Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
9.3 UAE Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
9.4 Egypt Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
9.5 South Africa Genomics In Cancer Care Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Genomics In Cancer Care Revenue and Market Share by Type (2015-2020)
10.2 Global Genomics In Cancer Care Market Forecast by Type (2019-2024)
10.3 Instruments Revenue Growth Rate (2015-2025)
10.4 Consumables Revenue Growth Rate (2015-2025)
10.5 Services Revenue Growth Rate (2015-2025)
11 Global Genomics In Cancer Care Market Segment by Application
11.1 Global Genomics In Cancer Care Revenue Market Share by Application (2015-2020)
11.2 Genomics In Cancer Care Market Forecast by Application (2019-2024)
11.3 Diagnostics Revenue Growth (2015-2020)
11.4 Personalized Medicine Revenue Growth (2015-2020)
11.5 Drug Discovery Revenue Growth (2015-2020)
11.6 Development Revenue Growth (2015-2020)
11.7 Research Revenue Growth (2015-2020)
12 Global Genomics In Cancer Care Market Size Forecast (2021-2025)
12.1 Global Genomics In Cancer Care Market Size Forecast (2021-2025)
12.2 Global Genomics In Cancer Care Market Forecast by Regions (2021-2025)
12.3 North America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
12.4 Europe Genomics In Cancer Care Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Genomics In Cancer Care Revenue Market Forecast (2021-2025)
12.6 South America Genomics In Cancer Care Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Genomics In Cancer Care Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【掲載企業】

Illumina、Danaher、Roche、Thermo Fisher scientific、Bio-Rad、Agilent、Pacific Biosciences、Beckman Coulter、Cancer Genetics、Sigma Aldrich、Qiagen、Quest Diagnostics、GE Healthcare、PerkinElmer、Luminex、Thermo Fisher scientific、Oxford Gene Technology

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のがん治療におけるゲノミクス市場2020年:企業別・地域別・種類別・用途別市場予測(~2025年)(Global Genomics In Cancer Care Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。